A. Scalfari, A. Neuhaus, A. Degenhardt, G. Rice, and P. Muraro, The natural history of multiple sclerosis, a geographically based study 10: Relapses and long-term disability, Brain, vol.133, pp.1914-1943, 2010.

D. Miller, F. Barkhof, X. Montalban, A. Thompson, and M. Filippi, Clinically isolated syndromes suggestive of multiple sclerosis, part 2: Non-conventional MRI, recovery processes, and management, The Lancet Neurology, vol.4, pp.341-348, 2005.

J. Marriott, J. Miyasaki, G. Gronseth, O. Connor, and P. , Evidence report: The efficacy and safety of mitoxantrone (no-vantrone) in the treatment of multiple sclerosis: Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology, Neurology, vol.74, p.14631470, 2010.

E. Fox, Management of worsening multiple sclerosis with mitoxantrone: A review, clinical therapeutics. Neu-rology, vol.28, p.461474, 2006.

A. Compston and A. Coles, Multiple sclerosis, Lancet, vol.3722, pp.1502-1517, 2001.
URL : https://hal.archives-ouvertes.fr/hal-00996686

B. Trapp, J. Peterson, R. Ransohoff, R. Rudick, and S. Mork, Axonal transection in the lesions of multiple sclerosis, New England Journal Medicine, vol.338, pp.278-285, 1998.

A. Bitsch, J. Schuchartdt, S. Bunkowski, T. Kuhlmann, and W. Brueck, Acute axonal injury in multiple sclerosisfvf. correlation with demyelination and inammation, Brain, vol.123, pp.1174-1183, 2000.

F. Aboul-enein, P. Weiser, R. Hoeftberger, H. Lassmann, and M. Bradl, Transient axonal injury in the absence of demyelination: A correlate of clinical disease in acute experimental autoimmune encephalomyelitis, Acta Neuropathology, vol.111, pp.539-586, 2006.

K. Smith, R. Kapoor, S. Hall, and M. Davies, Electrically active axons degenerate when exposed to nitric oxide, Annals of Neurology, vol.49, pp.470-476, 2001.
DOI : 10.1002/ana.96.abs

E. Redford, R. Kapoor, and K. Smith, Nitric oxide donors reversibly block axonal conduction: Demyelinated axons are especially susceptible, Brain, vol.120, pp.2149-2157, 1997.
DOI : 10.1093/brain/120.12.2149

URL : https://academic.oup.com/brain/article-pdf/120/12/2149/17862027/1202149.pdf

H. Lassman, Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models, Experimental neurology, vol.225, pp.2-8, 2010.

B. Kornek and H. Lassmann, Axonal pathology in multiple sclerosis. A historical note, Brain pathology, vol.9, pp.651-656, 1999.

V. Dousset, B. Doche, K. Petry, B. Brochet, and C. Delalande, Correlation between clinical status and macrophage activity imaging in the central nervous system of rats, Academic Radiology, vol.9, pp.156-165, 2002.

V. Dousset, B. Brochet, M. Deloire, L. Lagoarde, and B. Barroso, MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium, American Journal of Neuroradiology, vol.27, pp.1000-1005, 2006.

T. Tourdias, S. Roggerone, M. Filippi, M. Kanagaki, and M. Rovaris, Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium-and superparamagnetic iron oxide-enhanced MR imaging, Radiology, vol.264, pp.225-233, 2012.

M. Vellinga, R. Oude-engberink, A. Seewann, P. Pouwels, and M. Wattjes, Pluriformity of inammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement, Brain, vol.131, pp.800-807, 2008.

M. Van-walderveen, W. Kamphorst, P. Scheltens, J. Van-waesberghe, and R. Ravid, Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis, Neurology, vol.50, pp.1282-1288, 1998.

M. Van-walderveen, F. Barkhof, O. Hommes, C. Polman, and H. Tobi, Correlating MRI and clinical disease activity in multiple sclerosis: Relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images, Neurology, vol.454, p.16841690, 1995.

L. Truyen, J. Van-waesberghe, M. Van-walderveen, B. Van-oosten, and C. Polman, Accumulation of hypointense lesions (''black holes'') on T1 spinecho MRI correlates with disease progression in multiple sclerosis, Neurology, vol.47, pp.1469-1476, 1996.

M. Filippi, M. Horsfield, S. Morrissey, D. Macmanus, and P. Rudge, Quantitative brain lesion load predicts the course of CIS, Neurology, vol.44, pp.635-641, 1994.

P. Brex, O. Ciccarelli, J. O'riordan, M. Sailer, and A. Thompson, A longitudinal study of abnormalities on MRI and disability from multiple sclerosis, New England Journal of Medicine, vol.346, pp.158-164, 2002.

C. Polman, S. Reingold, G. Edan, M. Filippi, and H. Hartung, Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria, Annals of Neurology, vol.58, pp.840-846, 2005.
DOI : 10.1002/ana.22366

URL : http://onlinelibrary.wiley.com/doi/10.1002/ana.22366/pdf

J. Kurtzke, Rating neurologic impairment in multiple sclerosis: An expanded disability status scale, Neurology, vol.33, pp.1444-1452, 1983.
DOI : 10.1212/wnl.33.11.1444

URL : http://www.neurology.org/content/33/11/1444.full.pdf

W. Mcdonald, A. Compston, G. Edan, D. Goodkin, and H. Hartung, Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis, Annals of Neurology, vol.502, pp.121-127, 2001.

P. Brex, K. Miszkiel, J. O'riordan, G. Plant, and I. Moseley, Assessing the risk of early MS in patients with clinically isolated syndromes the role of followup MRI, Journal of Neurological Neurosurgery and Psychiatry, vol.70, pp.390-393, 2001.

F. Barkhof, J. Waesberghe, M. Filippi, T. Yousry, and D. Miller, T1 hypointense lesions in secondary progressive multiple sclerosis: effet of interferon beta-1b treatment, Brain, vol.124, pp.1396-1402, 2001.
DOI : 10.1093/brain/124.7.1396

URL : https://academic.oup.com/brain/article-pdf/124/7/1396/802912/1241396.pdf